DocuSign (NASDAQ: DOCU) was one of the best-positioned companies to benefit from the pandemic. The company's e-signature platform boomed as industries that had resisted the technology had little ...
We are lowering our fair value estimate for narrow-moat DocuSign to $244 per share, from $290, as we have adjusted our model based on near-term guidance, which reduces our growth forecast over the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results